Edit
Farallon Capital Management, L.L.C.
http://www.faralloncapital.com/Last activity: 14.03.2025
Active
We pursue multiple investment strategies on an opportunistic basis.
Employees: 51-200
Founded date: 1986
Mentions in press and media 17
| Date | Title | Description |
| 15.03.2025 | Pentera Secures $60 Million to Fortify Cybersecurity Landscape | In a world where cyber threats loom like dark clouds, Pentera has emerged as a beacon of hope. The Boston-based company, specializing in automated security validation, recently secured $60 million in Series D funding. This round was led by ... |
| 14.03.2025 | Pentera: $60 Million (Series D) Secured For Leading Security Validation Market Consolidation | Pentera, a leader in automated security validation, today announced a $60 million Series D funding round led by Evolution Equity Partners, with participation from Farallon Capital Management, bringing the company’s total funding to $250 mil... |
| 12.03.2025 | Pentera Raises $60M in Series D Funding | Pentera, a Boston, MA-based automated security validation company, raised $60M in Series D Funding. The round was led by Evolution Equity Partners, with participation from Farallon Capital Management, bringing the the total funding to $250M... |
| 18.12.2024 | Bain and KKR battle for Fuji Soft heats up as Bain goes hostile | TOKYO :Bain Capital said on Wednesday it plans to launch a tender offer for Fuji Soft shares even without the backing of the Japanese firm's board should a second-round bid from rival suitor KKR fail. The estimated $2 billion bid for just u... |
| 17.12.2024 | Fuji Soft sticks with KKR, rejects Bain's raised buyout offer | Japanese IT firm Fuji Soft has reaffirmed its support for the second stage of a tender offer buyout from US private equity firm KKR and came out against a higher offer from rival Bain Capital, it said in a statement on Tuesday. KKR now owns... |
| 17.12.2024 | Fuji Soft rejects Bain's raised buyout offer and sticks with KKR | TOKYO : Japanese IT firm Fuji Soft has reaffirmed its support for the second stage of a tender offer buyout from U.S. private equity firm KKR and came out against a higher offer from rival Bain Capital, it said in a statement on Tuesday. KK... |
| 09.09.2024 | Пионер ксенотрансплантации eGenesis собрал $191 млн для генно-редактированных органов свиньи | Компания eGenesis уже попала в заголовки новостей благодаря трансплантации органов свиньи. В марте 2024 года eGenesis объявила о первой в мире успешной пересадке почки свиньи живому пациенту. Трансплантация была одобрена FDA в рамках расшир... |
| 04.09.2024 | eGenesis Raises $191M in Series B Funding | eGenesis, a Cambridge, MA-based biotechnology company developing human-compatible engineered organs to address the global organ shortage, raised $191M in Series B funding. The round was led by Lux Capital, with participation from existing i... |
| 04.09.2024 | eGenesis: $191 Million (Series D) Secured To Develop Engineered Organs For Addressing Transplant Shortages | eGenesis, a biotechnology company that is developing human-compatible engineered organs to address the global organ shortage, announced today the closing of a $191 million Series D financing. The funding was led by Lux Capital, with partici... |
| 08.07.2024 | CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP | BEIJING, July 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products today announces a... |
Show more